HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
CDC: Adults need only one updated COVID booster shot, for now
By
Alicia Lasek
Mar 30, 2023
The CDC does not recommend more than one updated COVID-19 booster shot at this time for adults who have completed their primary series of vaccinations.
Early screening curbs C. auris in ventilator-assisted facilities: study
By
Alicia Lasek
Feb 02, 2023
Targeted screening for Candida auris at admission to ventilator-assisted units in nursing homes helps to identify colonized residents, physician researchers report.
AHCA/NCAL: When inspected during pandemic, most nursing homes deficiency-free
By
Alicia Lasek
Mar 28, 2022
Despite navigating unprecedented hardship and loss during the pandemic, there is evidence that care in nursing homes held steady in a number of quantifiable areas, according to the organization’s...
Results of CMS initiative support on-site acute care in nursing homes
By
Alicia Lasek
Jun 09, 2023
On-site acute care in the nursing home did not result in any harm and appeared to benefit long-stay residents, outcomes from a multi-state initiative revealed. Investigators are urging medical directors...
HHS to extend PREP Act protections for pharmacy workers after end of PHE
By
Alicia Lasek
Apr 16, 2023
Pharmacy providers will continue to have liability immunity when administering COVID-19 and vaccinations, treatments and tests after the end of the Public Health Emergency, the Department of Health and...
Use the ‘5 C’s’ to tackle COVID vaccine hesitancy, physicians say
By
Alicia Lasek
Jun 04, 2021
The reasons for vaccine hesitancy — a delay in acceptance or refusal to be vaccinated — can be boiled down to five important factors that may help clinicians understand and better approach this issue,...
Omicron BA.2 subvariant tied to less severe illness than delta, original omicron
Oct 28, 2022
Mortality rates are lower for omicron BA.2 than for delta variant and early omicron, investigators report.
FDA authorizes omicron-targeting vaccines as preferred COVID booster shots
By
Alicia Lasek
Sep 01, 2022
The FDA has authorized new, bivalent versions of Pfizer’s and Moderna’s COVID-19 vaccines to be used as booster shots. At the same time, the original monovalent versions are no longer authorized as...
CDC: C. auris spreading at ‘alarming’ rate in U.S. healthcare facilities
By
Alicia Lasek
Mar 22, 2023
Drug-resistant Candida auris, a known threat to nursing homes, has spread rapidly, and a growing number of cases are resistant to first-line treatment, federal researchers report.